MC
Matrix Capital Management
GeneralistWaltham, United States
Stage FocusSeries A, Series B+
GeographyUS
TypeHedge Fund
Last Activity2024
Industry Focus
Industries
SemiconductorsAIBiotech
Technical BenchStrong
Investor TypeGeneralist
ExposureSome DeepTech Investments
Bio
Matrix Capital Management is a hedge fund founded in 1999 by David Goel, based in Waltham, Massachusetts, managing $5B in AUM as of March 2025 for just 4 clients. In August 2024, Goel announced the fund's closure due to health issues.
The investment approach was a concentrated portfolio of long/short positions primarily in public equities, with a portion allocated to private companies. Focus area...
Notable Investments
M
Maze TherapeuticsSimilar Funds
Samsung Venture Investment Corporation
Seoul, South Korea
GeneralistSemiconductorsBiotechAISeedSeries A
Texas Ventures
Houston, Texas, United States
GeneralistSemiconductorsBiotechMobilitySeedSeries A
Atinum Investment
South Korea
GeneralistSemiconductorsRoboticsAISeedSeries A
CDIB Capital
Taipei, Taiwan
GeneralistSemiconductorsBiotechMedtechSeedSeries A
Celesta Capital
Silicon Valley, United States
DeepTech NativeSemiconductorsAIAdvanced MaterialsSeries ASeries B+
Co-Stone Venture Capital (CoStone Capital)
Shenzhen, China
GeneralistSemiconductorsMedtechAdvanced ManufacturingSeries ASeries B+